DuPont Nutrition & Biosciences announced today the mechanical completion of its new Flexiblend facility in Singapore. The new plant will leverage on DuPont’s advanced biotechnology and global quality standards to provide customized solutions to industry partners in Asia Pacific and will begin operations in 2nd quarter of 2021.
Overcoming the challenges that COVID-19 created, the construction team sought alternative ways to ensure that this state-of-the art facility would become a reality with minimal delay. From using virtual reality technology to compensate for the distance between global and local engineering teams, to creating temporary on-site living quarters for the crew to adhere to safety guidelines, the team delivered mechanical completion of the plant efficiently.
Biotechnology solutions produced in the plant will include flexible blending of enzymes, customized for Asia. Enzymes are highly specialized proteins that improve the sustainability of conventional processes by reducing the use of chemicals, enabling energy efficiency, water efficiency, and waste reduction. Enzymes are used in a wide range of applications such as animal nutrition, grain processing, home care, food & beverage and many others.
